Surgical Advances in Inguinal Lymph Node Dissection




Lymphadenectomy (LND) for locally advanced penile cancer is often necessary in patients with suspected disease within the inguinal or pelvic lymph nodes because the results of systemic therapy are somewhat marginal. It has utility in staging, disease prognosis, and treatment in certain men because early dissection of involved lymph nodes improves survival. Despite its mainstay in the management of this disease, inguinal and pelvic lymph node dissection can be associated with significant postoperative complications and patient morbidity. Recent refinements in surgical technique, however, and appropriate patient selection can minimize these risks and lead to better short-term and long-term outcomes.





  • For men with 2 or more positive ILNs or inguinal extracapsular extension (pN3), an ipsilateral or bilateral PLND is indicated for appropriate surgical treatment and staging.





  • For men with 2 or more positive ILNs or inguinal extracapsular extension (pN3), an ipsilateral or bilateral PLND is indicated for appropriate surgical treatment and staging.






  • A summarized algorithm of the clinical indications for lymphadenectomy for penile carcinoma is provided in Fig. 2 .




    Fig. 2


    Flow diagram for the management of ILNs in patients with penile cancer. ENE, extranodal extension; FNA, fine needle aspiration; U/S, ultrasound.

    ( Adapted from Protzel C, Alcaraz A, Horenblas S, et al. Lymphadenectomy in the surgical management of penile cancer. Eur Urol 2009;55(5):1075–88; with permission.)










    The distal attachments of the rectus abdominis muscle to the pubic bone may sometimes be incised to allow for additional mobility of the flap. Doppler ultrasound also may be used to ensure adequate blood supply from the pedicle of the RAM flap. Last, the island of skin and subcutaneous tissue between the base of the flap and the recipient site is incised to the level of the external oblique aponeurosis. The apical portion of the flap is then tunneled to the groin defect and secured appropriately.








    Patients with metastatic node-positive disease have a recurrence rate of 19%, so imaging of the chest, abdomen, and pelvis with CT, MRI, or PET-CT is recommended at 3-month to 6-month intervals for the first 2 years due to the risk of development of locoregional or distant metastatic disease. This should complement routine physical examination, and these patients may benefit from adjuvant radiation therapy or systemic chemotherapy.


    References



    1. 1. Pow-Sang M.R., Ferreira U., Pow-Sang J.M., et al: Epidemiology and natural history of penile cancer. Urology 2010; 76: pp. S2-S6

    2. 2. Horenblas S.: Lymphadenectomy in penile cancer. Urol Clin North Am 2011; 38: pp. 459-469

    3. 3. Spiess P.E., and National Comprehensive Cancer Network : New treatment guidelines for penile cancer. J Natl Compr Canc Netw 2013; 11: pp. 659-662

    4. 4. Kayes O., Minhas S., Allen C., et al: The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 2007; 51: pp. 1313-1318

    5. 5. Powles T., Murray I., Brock C., et al: Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007; 51: pp. 1511-1520

    6. 6. Graafland N.M., Leijte J.A., Valdes Olmos R.A., et al: Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol 2009; 56: pp. 339-345

    7. 7. Rosevear H.M., Williams H., Collins M., et al: Utility of (1)(8)F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urol Oncol 2012; 30: pp. 723-726

    8. 8. Schlenker B., Scher B., Tiling R., et al: Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 2012; 30: pp. 55-59

    9. 9. Sadeghi R., Gholami H., Zakavi S.R., et al: Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med 2012; 37: pp. 436-441

    10. 10. Kroon B.K., Valdes Olmos R.A., van Tinteren H., et al: Reproducibility of lymphoscintigraphy for lymphatic mapping in patients with penile carcinoma. J Urol 2005; 174: pp. 2214-2217

    11. 11. Leijte J.A., Valdes Olmos R.A., Nieweg O.E., et al: Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol 2008; 54: pp. 885-890

    12. 12. Protzel C., Alcaraz A., Horenblas S., et al: Lymphadenectomy in the surgical management of penile cancer. Eur Urol 2009; 55: pp. 1075-1088

    13. 13. Wood H.M., and Angermeier K.W.: Anatomic considerations of the penis, lymphatic drainage, and biopsy of the sentinel node. Urol Clin North Am 2010; 37: pp. 327-334

    14. 14. Naumann C.M., Al-Najar A., Alkatout I., et al: Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density. BJU Int 2009; 103: pp. 1655-1659

    15. 15. Leijte J.A., Hughes B., Graafland N.M., et al: Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol 2009; 27: pp. 3325-3329

    16. 16. Hakenberg O.W., Comperat E.M., Minhas S., et al: EAU guidelines on penile cancer: 2014 update. Eur Urol 2015; 67: pp. 142-150

    17. 17. Bleeker M.C., Heideman D.A., Snijders P.J., et al: Penile cancer: epidemiology, pathogenesis and prevention. World J Urol 2009; 27: pp. 141-150

    18. 18. Theodorescu D., Russo P., Zhang Z.F., et al: Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. J Urol 1996; 155: pp. 1626-1631

    19. 19. Graafland N.M., Lam W., Leijte J.A., et al: Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients. Eur Urol 2010; 58: pp. 742-747

    20. 20. Hughes B.E., Leijte J.A., Kroon B.K., et al: Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Eur Urol 2010; 57: pp. 688-692

    21. 21. Kulkarni J.N., and Kamat M.R.: Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2A carcinoma of the penis. Eur Urol 1994; 26: pp. 123-128

    22. 22. McDougal W.S.: Preemptive lymphadenectomy markedly improves survival in patients with cancer of the penis who harbor occult metastases. J Urol 2005; 173: pp. 681

    23. 23. Kroon B.K., Horenblas S., Lont A.P., et al: Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 2005; 173: pp. 816-819

    24. 24. Kakies C., Lopez-Beltran A., Comperat E., et al: Reproducibility of histopathologic tumor grading in penile cancer–results of a European project. Virchows Arch 2014; 464: pp. 453-461

    25. 25. Heyns C.F., Fleshner N., Sangar V., et al: Management of the lymph nodes in penile cancer. Urology 2010; 76: pp. S43-S57

    26. 26. Naumann C.M., van der Horst S., van der Horst C., et al: Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes. Urol Oncol 2015; 33: pp. 389.e9-14

    27. 27. Saisorn I., Lawrentschuk N., Leewansangtong S., et al: Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int 2006; 97: pp. 1225-1228

    28. 28. Bermejo C., Busby J.E., Spiess P.E., et al: Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007; 177: pp. 1335-1338

    29. 29. Bouchot O., Rigaud J., Maillet F., et al: Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol 2004; 45: pp. 761-765

    30. 30. Liu J.Y., Li Y.H., Zhang Z.L., et al: The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol 2013; 31: pp. 1519-1524

    31. 31. Lont A.P., Kroon B.K., Gallee M.P., et al: Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 2007; 177: pp. 947-952

    32. 32. Zhu Y., Zhang S.L., Ye D.W., et al: Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet’s node, and disease burden of inguinal lymph nodes. Onkologie 2008; 31: pp. 37-41

    33. 33. Lughezzani G., Catanzaro M., Torelli T., et al: The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. J Urol 2014; 191: pp. 977-982

    34. 34. Wang J.Y., Zhu Y., Tang S.X., et al: Prognostic significance of the degree of extranodal extension in patients with penile carcinoma. Asian J Androl 2014; 16: pp. 437-441

    35. 35. Djajadiningrat R.S., van Werkhoven E., and Horenblas S.: Prophylactic pelvic lymph node dissection in patients with penile cancer. J Urol 2015; 193: pp. 1976-1980

    36. 36. Nelson B.A., Cookson M.S., Smith J.A., et al: Complications of inguinal and pelvic lymphadenectomy for squamous cell carcinoma of the penis: a contemporary series. J Urol 2004; 172: pp. 494-497

    37. 37. Zargar-Shoshtari K., Djajadiningrat R., Sharma P., et al: Establishing criteria for bilateral pelvic lymph node dissection in the management of penile cancer: lessons learned from an International Multicenter Collaboration. J Urol 2015; 194: pp. 696-701

    38. 38. Zargar-Shoshtari K., Sharma P., Djajadiningrat R., et al: Extent of pelvic lymph node dissection in penile cancer may impact survival. World J Urol 2016; 34: pp. 353-359

    39. 39. Giannatempo P, Paganoni A, Sangalli L, et al. Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): results of a single high-volume center. Paper presented at: Journal of Clinical Oncology. San Francisco, January 30-February 1, 2014.

    40. 40. Horenblas S.: Lymphadenectomy for squamous cell carcinoma of the penis. Part 2: the role and technique of lymph node dissection. BJU Int 2001; 88: pp. 473-483

    41. 41. Kean J., Hough M., and Stevenson J.H.: Skin excision and groin lymphadenectomy: techniques and outcomes. Lymphology 2006; 39: pp. 141-146

    42. 42. Koifman L., Hampl D., Koifman N., et al: Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. J Urol 2013; 190: pp. 2086-2092

    43. 43. Zhu Y., Gu C.Y., and Ye D.W.: Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma. Urol Int 2014; 92: pp. 186-193

    44. 44. Li Z.S., Yao K., Chen P., et al: Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density. Urol Oncol 2014; 32: pp. 893-900

    45. 45. Lughezzani G., Catanzaro M., Torelli T., et al: Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases. BJU Int 2015; 116: pp. 727-733

    46. 46. Gopman J.M., Djajadiningrat R.S., Baumgarten A.S., et al: Predicting postoperative complications of inguinal lymph node dissection for penile cancer in an international multicentre cohort. BJU Int 2015; 116: pp. 196-201

    47. 47. Bevan-Thomas R., Slaton J.W., and Pettaway C.A.: Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. J Urol 2002; 167: pp. 1638-1642

    48. 48. Stuiver M.M., Djajadiningrat R.S., Graafland N.M., et al: Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis. Eur Urol 2013; 64: pp. 486-492

    49. 49. Spiess P.E., Hernandez M.S., and Pettaway C.A.: Contemporary inguinal lymph node dissection: minimizing complications. World J Urol 2009; 27: pp. 205-212

    50. 50. Spiess P.E.: Penile cancer: diagnosis and treatment. Berlin (Germany): Springer Science & Business Media, 2013.

    51. 51. Catalona W.J.: Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results. J Urol 1988; 140: pp. 306-310

    52. 52. Yao K., Tu H., Li Y.H., et al: Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol 2010; 184: pp. 546-552

    53. 53. Yao K., Zou Z.J., Li Z.S., et al: Fascia lata preservation during inguinal lymphadenectomy for penile cancer: rationale and outcome. Urology 2013; 82: pp. 642-647

    54. 54. Jacobellis U.: Modified radical inguinal lymphadenectomy for carcinoma of the penis: technique and results. J Urol 2003; 169: pp. 1349-1352

    55. 55. Lopes A., Rossi B.M., Fonseca F.P., et al: Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer 1996; 77: pp. 2099-2102

    56. 56. Leijte J.A., Kirrander P., Antonini N., et al: Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008; 54: pp. 161-168

    57. 57. Baumgarten A.S., Alhammali E., Hakky T.S., et al: Salvage surgical resection for isolated locally recurrent inguinal lymph node metastasis of penile cancer: international study collaboration. J Urol 2014; 192: pp. 760-764

    58. 58. Aslim E.J., Rasheed M.Z., Lin F., et al: Use of the anterolateral thigh and vertical rectus abdominis musculocutaneous flaps as utility flaps in reconstructing large groin defects. Arch Plast Surg 2014; 41: pp. 556-561

    59. 59. Slavin S.A., and Goldwyn R.M.: The midabdominal rectus abdominis myocutaneous flap: review of 236 flaps. Plast Reconstr Surg 1988; 81: pp. 189-199

    60. 60. Sailon A.M., Schachar J.S., and Levine J.P.: Free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps for breast reconstruction: a systematic review of flap complication rates and donor-site morbidity. Ann Plast Surg 2009; 62: pp. 560-563

    61. 61. Kanchwala S.K., and Bucky L.P.: Precision transverse rectus abdominis muscle flap breast reconstruction: a reliable technique for efficient preoperative planning. Ann Plast Surg 2008; 60: pp. 521-526

    62. 62. Gutarra F., Asensio J.R., Kohan G., et al: Closure of a contained open abdomen using a bipedicled myofascial oblique rectus abdominis flap technique. J Plast Reconstr Aesthet Surg 2009; 62: pp. 1490-1496

    63. 63. Chen J.J., Giese S., Jeffrey R.B., et al: Treatment and stabilization of complex wounds involving the pelvic bone, groin, and femur with the inferiorly based rectus abdominis musculocutaneous flap and the use of power color Doppler imaging in preoperative evaluation. Ann Plast Surg 1999; 43: pp. 494-498

    64. 64. Georgieu N., Watier E., Fadhul S., et al: Value of pulsed color Doppler before transverse rectus abdominis musculocutaneous flap breast reconstruction. 45 cases. Ann Chir Plast Esthet 2000; 45: pp. 516-521

    65. 65. Carmignani G.: Words of wisdom. Re: Video endoscopic lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. Eur Urol 2008; 53: pp. 451-452

    66. 66. Tobias-Machado M., Tavares A., Ornellas A.A., et al: Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol 2007; 177: pp. 953-957

    67. 67. Pahwa H.S., Misra S., Kumar A., et al: Video endoscopic inguinal lymphadenectomy (VEIL)–a prospective critical perioperative assessment of feasibility and morbidity with points of technique in penile carcinoma. World J Surg Oncol 2013; 11: pp. 42

    68. 68. Tobias-Machado M., Tavares A., Silva M.N., et al: Can video endoscopic inguinal lymphadenectomy achieve a lower morbidity than open lymph node dissection in penile cancer patients? J Endourol 2008; 22: pp. 1687-1691

    69. 69. Autorino R., Zargar H., Akca O., et al: Robot-assisted laparoendoscopic single-site inguinal lymphadenectomy: initial investigation in a cadaver model. Minerva Urol Nefrol 2016; 68: pp. 311-314

    70. 70. Josephson D.Y., Jacobsohn K.M., Link B.A., et al: Robotic-assisted endoscopic inguinal lymphadenectomy. Urology 2009; 73: pp. 167-170

    71. 71. Sotelo R., Cabrera M., Carmona O., et al: Robotic bilateral inguinal lymphadenectomy in penile cancer, development of a technique without robot repositioning: a case report. Ecancermedicalscience 2013; 7: pp. 356

    72. 72. Matin S.F., Cormier J.N., Ward J.F., et al: Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int 2013; 111: pp. 1068-1074

    73. 73. Kharadjian T.B., Matin S.F., and Pettaway C.A.: Early experience of robotic-assisted inguinal lymphadenectomy: review of surgical outcomes relative to alternative approaches. Curr Urol Rep 2014; 15: pp. 412

    74. 74. Djajadiningrat R.S., Graafland N.M., van Werkhoven E., et al: Contemporary management of regional nodes in penile cancer—improvement of survival? J Urol 2014; 191: pp. 68-73

    75. 75. Djajadiningrat R.S., Teertstra H.J., van Werkhoven E., et al: Ultrasound examination and fine needle aspiration cytology—useful for followup of the regional nodes in penile cancer? J Urol 2014; 191: pp. 652-655

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

    Mar 3, 2017 | Posted by in UROLOGY | Comments Off on Surgical Advances in Inguinal Lymph Node Dissection

    Full access? Get Clinical Tree

    Get Clinical Tree app for offline access